Literature DB >> 24016623

Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.

Shigemasa Tani1, Michiaki Matsumoto2, Ken Nagao2, Atsushi Hirayama3.   

Abstract

BACKGROUND: Despite well-controlled low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia is an independent predictor of coronary events. We investigated the risk of atherosclerotic cardiovascular disease through examining the relation between triglyceride (TG) metabolism and LDL-heterogeneity as assessed by polyacrylamide-gel electrophoresis (PAGE). METHODS AND
RESULTS: Estimated LDL-particle size [relative LDL migration (LDL-Rm value)] measured by PAGE with the LipoPhor system (Joko, Tokyo, Japan) was evaluated in 645 consecutive patients with one additional risk factor for atherosclerotic cardiovascular disease.Multivariate regression analysis after adjustments for traditional risk factors revealed an elevated triglyceride-rich lipoproteins (TRLs)-related markers [TG, remnant-like particle cholesterol (RLP-C), very LDL (VLDL) fraction, apolipoprotein (apo) C-II, and apo C-III] level to be an independent predictor of smaller-size LDL-particle size, both in the overall population, and in a subset of patients with serum LDL-C <100 mg/dL. Even among the patients with LDL-C levels <100 mg/dL, the serum levels of atherogenic lipid markers in those with a LDL-Rm value ≥0.40, suggesting the presence of large amounts of small-dense LDL and upper limit (mean+2 standard deviation) in this population, were significantly higher than in those with a LDL-Rm value <0.40. Moreover, the serum levels of TRLs-related markers showed high accurate area under the receiver-operating characteristic curve (TG, 0.896; RLP-C, 0.875; VLDL fraction, 0.803; apo C-II, 0.778; and apo C-III, 0.804, respectively) in terms of evaluation of the indicators of LDL-Rm value ≥0.40.
CONCLUSION: To further reduce the risk of atherosclerotic cardiovascular disease, it may be of particular importance to pay attention not only to the quantitative change in the serum LDL-C, but also TG-metabolism associated with LDL-heterogeneity. Combined evaluation of TRLs-related markers and LDL-Rm value may be useful for assessing the risk of atherosclerotic cardiovascular disease.
Copyright © 2013 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Low-density lipoprotein heterogeneity; Triglyceride; Triglyceride-rich lipoproteins

Mesh:

Substances:

Year:  2013        PMID: 24016623     DOI: 10.1016/j.jjcc.2013.06.018

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  11 in total

1.  Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.

Authors:  Shigemasa Tani; Atsuhiko Takahashi; Ken Nagao; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2015-04-19       Impact factor: 2.037

2.  Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.

Authors:  Katsuaki Yokoyama; Shigemasa Tani; Rei Matsuo; Naoya Matsumoto
Journal:  Heart Vessels       Date:  2018-08-23       Impact factor: 2.037

3.  Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method.

Authors:  Bárbara Fernández-Cidón; Ariadna Padró-Miquel; Pedro Alía-Ramos; María José Castro-Castro; Marta Fanlo-Maresma; Dolors Dot-Bach; José Valero-Politi; Xavier Pintó-Sala; Beatriz Candás-Estébanez
Journal:  Vasc Health Risk Manag       Date:  2017-06-06

4.  Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.

Authors:  Katsuaki Yokoyama; Shigemasa Tani; Rei Matsuo; Naoya Matsumoto
Journal:  BMC Cardiovasc Disord       Date:  2018-12-05       Impact factor: 2.298

5.  High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease.

Authors:  Fumiaki Ito; Tomoyuki Ito
Journal:  Antioxidants (Basel)       Date:  2020-04-26

6.  Lipid levels after childbirth and association with number of children: A population-based cohort study.

Authors:  Aleksandra Pirnat; Lisa A DeRoo; Rolv Skjærven; Nils-Halvdan Morken
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

7.  Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis.

Authors:  Yan-Yan Qi; Li Yan; Zhong-Min Wang; Xi Wang; Hua Meng; Wen-Bo Li; Dong-Chang Chen; Meng Li; Jun Liu; Song-Tao An
Journal:  Diabetol Metab Syndr       Date:  2021-01-29       Impact factor: 3.320

8.  A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity.

Authors:  Shigemasa Tani; Rei Matsuo; Kenji Kawauchi; Tsukasa Yagi; Wataru Atsumi; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2017-11-20       Impact factor: 2.037

9.  Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.

Authors:  Shigemasa Tani; Tsukasa Yagi; Wataru Atsumi; Kenji Kawauchi; Rei Matsuo; Atsushi Hirayama
Journal:  Cardiovasc Diabetol       Date:  2017-10-02       Impact factor: 9.951

10.  Effects of Polyphenol Compounds and Nitrogen Oxide Donors on Lipid Oxidation, Membrane-Skeletal Proteins, and Erythrocyte Structure under Hypoxia.

Authors:  Viсtor V Revin; Natalia V Gromova; Elvira S Revina; Ksenia V Prosnikova; Nadezhda V Revina; Svetlana S Bochkareva; Olga G Stepushkina; Igor P Grunyushkin; Marina R Tairova; Vera I Incina
Journal:  Biomed Res Int       Date:  2019-12-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.